Related Experiment Video
Updated: May 28, 2025
07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
397
Endothelial protease-activated receptor 4: impotent or important?
Rahul Rajala1,2,3, Courtney T Griffin1,2
1Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Frontiers in Cardiovascular Medicine
|February 12, 2025
Summary
Protease-activated receptor 4 (PAR4) is functional in liver endothelial cells, challenging previous beliefs. Its low expression is due to high potency, not lack of function, opening new research avenues in vascular biology.
Area of Science:
- Vascular Biology
- Cell Signaling
- G protein-coupled receptors
Background:
- Thrombin signals via protease-activated receptors 1 and 4 (PAR1/PAR4) on endothelial cells (ECs).
- PAR4 function in ECs has been debated, with many studies suggesting it is primarily active on platelets.
- Previous research indicated a lack of PAR4 functionality in ECs.
Purpose of the Study:
- To investigate the presence and function of PAR4 in hepatic ECs.
- To reconcile the controversy surrounding PAR4's role in ECs.
- To propose a new understanding of PAR4 expression regulation based on its signaling potency.
Main Methods:
- In vivo identification of PAR4 expression in hepatic ECs.
- Comparative analysis of PAR4 and PAR1 signaling potency in ECs.
Main Results:
- Identified low but functional PAR4 expression in hepatic ECs in vivo.
- Demonstrated that PAR4 signaling potency is likely higher than PAR1.
- Proposed that low PAR4 expression is a regulatory mechanism for its high potency.
Conclusions:
- PAR4 is not functionally deficient in ECs; its low expression is linked to its potent signaling.
- This finding challenges the long-held view of PAR4's limited role in ECs.
- Highlights the need for further research into endothelial PAR4 regulation and its interplay with PAR1 in vascular biology.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
131
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
131
01:22Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K